Skip to search formSkip to main contentSkip to account menu

Carbidopa / Levodopa

Known as: Carbidopa and Levodopa, co careldopa, carbidopa-levodopa 
National Institutes of Health

Related topics

Related topics

17 relations

Broader (4)

Antiparkinson AgentsDopamine AgonistsDrug CombinationsImmunologic Adjuvants
CarbidopaCarbidopa 10 MG / Levodopa 100 MG Disintegrating Oral TabletCarbidopa 10 MG / Levodopa 100 MG Oral TabletCarbidopa 25 MG / Levodopa 100 MG Disintegrating Oral Tablet

Narrower (7)

GrifoparkinIPX066NacomNumient

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa…
IPX066 (extended‐release carbidopa‐levodopa [ER CD‐LD]) is an oral extended‐release capsule formulation of carbidopa and levodopa… 
Highly Cited
2014
Highly Cited
2014
Double‐blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease
The objective of this study was to assess the efficacy, safety, and pharmacokinetics of XP21279‐carbidopa in patients with… 
Highly Cited
2014
Highly Cited
2014
Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients.
Highly Cited
2011
Highly Cited
2011
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
The objective of the study was to compare the pharmacokinetics, motor effects, and safety of IPX066, a novel extended‐release… 
2004
2004
Frontotemporal dementia with ubiquitinated neuronal inclusions presenting with primary lateral sclerosis and parkinsonism: clinicopathological report of an autopsy case
We report a case displaying upper motor sign, parkinsonism, and behavioral abnormality, with marked degeneration of the… 
Highly Cited
2003
Highly Cited
2003
Effects of fatigue on physical activity and function in patients with Parkinson’s disease
Objective: To characterize the relationships between symptoms of fatigue, physical activity, physical function, and functional… 
Review
2002
Review
2002
Dysautonomias: Clinical Disorders of the Autonomic Nervous System
Drs. David S. Goldstein and Graeme Eisenhofer (Clinical Neurocardiology Section, National Institute of Neurological Disorders and… 
Highly Cited
2000
Highly Cited
2000
The effect of pregnancy in Parkinson's disease
Pregnancy in patients with Parkinson's disease (PD) is a rare occurrence. Previous reports based on retrospective analysis… 
Highly Cited
1986
Highly Cited
1986
Pharmacologic treatment of parkinsonian tremor.
The relative efficacy of trihexiphenidyl hydrochloride, amantadine hydrochloride, and low-dose carbidopa-levodopa in reducing… 
Highly Cited
1985
Highly Cited
1985
Motor function in the normal aging population: treatment with levodopa.
In normal elderly humans there is progressive motor dysfunction and loss of nigrostriatal neurons and brain dopamine similar to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)